Pharmacia Shifts Celebrex From Burnett to JWT

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK–Two days after losing a pitch for a new arthritis drug that will be co-marketed by Pfizer and Pharmacia, J. Walter Thompson in New York has landed ad duties for Pharmacia’s Celebrex, sources said. Billings are estimated at $80-$100 million.

The Celebrex account, which had not been in review, is suddenly being shifted from Leo Burnett in Chicago, which landed it in 1998. JWT could not immediately be reached but sources indicated that Peter Schweitzer, the agency’s worldwide CEO, announced the win internally on Wednesday.

Earlier



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in